How best to serve patients' interests in large clinical trials? Martine Piccart, Aron Goldhirsch and their colleagues argue that maintaining academic independence is essential to early breast cancer trials.
References
Early Breast Cancer Trialists' Collaborative Group Lancet 365, 1687–717 (2005).
Giordano, S. H., Duan, Z., Kuo, Y. F., Hortobagyi, G. N. & Goodwin, J. S. J. Clin. Oncol. 18, 2750–2756 (2006).
Regan, M. M. & Gelber, R. D. Breast 14, 582–593 (2005).
NIH Adjuvant Therapy for Breast Cancer available at http://consensus.nih.gov/2000/2000AdjuvantTherapyBreastCancer114html.htm (2000).
Mello, M. M., Clarridge, B. R. & Studdert, D. M. N. Engl. J. Med. 352, 2202–2210 (2005).
Gilpin, K. N. New York Times (2 June 2004).
Angell, M. The New York Review of Books 53(10), (2006).
Drazen, J. M. N. Engl. J. Med. 347, 1362–1363 (2002).
World Medical Association Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm).
Goss, P. E. et al. N. Engl. J. Med. 349, 1793–1802 (2003).
Piccart-Gebhart, M. J. et al. N. Engl. J. Med. 353, 1659–1672 (2005).
Thürlimann, B. et al. N. Engl. J. Med. 353, 2747–2757 (2005).
Coombes, R. C. et al. N. Engl. J. Med. 350, 1081–1092 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piccart, M., Goldhirsch, A., Wood, W. et al. Keeping faith with trial volunteers. Nature 446, 137–138 (2007). https://doi.org/10.1038/446137a
Published:
Issue Date:
DOI: https://doi.org/10.1038/446137a
- Springer Nature Limited
This article is cited by
-
Concordance as evidence in the Watson for Oncology decision-support system
AI & SOCIETY (2020)
-
Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward
Blood Cancer Journal (2016)
-
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Breast Cancer Research (2009)
-
Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
Nature Reviews Cancer (2007)